Concepedia

Christopher W. Rowe

CW

Statistics

Publications

16

Citations

418

H-Index

14

Active since

2013

Affiliations

University of Newcastle Australia(Current)

John Hunter Hospital

Hunter Medical Research Institute

University of New England

Christopher W. Rowe is an author at University of Newcastle Australia specializing in medicine, pathology, and embryology.

ORCID

Top concepts

Publications per year

2013–2023

16

Publications

16

Neurotrophin Receptors TrkA, p75NTR, and Sortilin Are Increased and Targetable in Thyroid Cancer

Sam Faulkner, Philip Jobling, Christopher W. Rowe et al. · American Journal Of Pathology · 2017 · 57 citations · Full text

, , +9

Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion

Christopher W. Rowe, Tony Dill, Nathan Griffin et al. · Scientific Reports · 2020 · 43 citations · Full text

The neurotrophic tyrosine kinase receptor TrkA and its ligand NGF are increased in squamous cell carcinomas of the lung

Fangfang Gao, Nathan Griffin, Sam Faulkner et al. · Scientific Reports · 2018 · 40 citations · Full text

Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 2013;36:2981–2987

EM Moore, AG Mander, David Ames et al. · Diabetes Care · 2013 · 30 citations · Full text

Antenatal corticosteroid administration for foetal lung maturation

Katie Wynne, Christopher W. Rowe, Matthew Delbridge et al. · F1000Research · 2020 · 30 citations · Full text

, , +23

1–5 of 16